James Hindman
Director/Board Member at ACCURAY INCORPORATED
Net worth: 421 616 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Robinson | M | 54 | 5 years | |
Thierry Abribat | M | - |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI.
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | 10 years |
Suzanne Winter | F | 61 | 5 years | |
David Pyott | M | 70 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | 18 years |
Thomas Lash | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
Randall W. Whitcomb | M | 69 |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | 8 years |
Leon Ekchian | M | 67 |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | 16 years |
David Hayes | M | 69 |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | 10 years |
Aimee Weisner | F | 55 |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | 15 years |
Carole Nüchterlein | F | 62 |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | 7 years |
Matthew Maletta | M | 52 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | - |
Joseph Whitters | M | 66 | 6 years | |
Mary Lynne Hedley | M | 61 |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | 7 years |
Nori Ebersole | F | 60 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 29 years |
Jesse Chew | M | 43 | 10 years | |
Ali Pervaiz | M | 44 | 4 years | |
Edward Armstrong | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
Shigeyuki Nishinaka | M | 59 | 5 years | |
Mika Nishimura | F | 60 | 3 years | |
Shane Martin | M | - |
Loyola Marymount University
| 5 years |
Byron Scott | M | 61 | 3 years | |
Sef P. Kurstjens | M | 60 | 6 years | |
John Buan | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
Michael Culler | M | - |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | 6 years |
Timothy Wojciechowski | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
Ryan Kubota | M | - | - | |
Colin Kealey | M | - |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | - |
Anne Le Grand | F | 73 | 4 years | |
Richard Middaugh | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
James Barlow | M | 65 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | 14 years |
Beverly A. Huss | F | 64 | 6 years | |
Christine Ocampo | F | 51 | - | |
Robert Kill | M | 60 | 1 years | |
Yvonne Slaught | F | - |
Loyola Marymount University
| - |
Melanie Gebauer | F | - | - | |
Edward Siebert | M | - |
Loyola Marymount University
| - |
Helen Lawrence | F | - |
Loyola Marymount University
| - |
Denise Richards | F | - |
Loyola Marymount University
| - |
Jerry Mook | M | - |
Loyola Marymount University
| - |
Donald Tarantino | M | - |
Loyola Marymount University
| - |
John Moutes | M | - |
Loyola Marymount University
| - |
Paul Fieberg | M | - |
Loyola Marymount University
| - |
Chris Pearson | M | - |
Loyola Marymount University
| - |
Grover McKean | M | - |
Loyola Marymount University
| - |
Katherine Moret | F | - |
Loyola Marymount University
| - |
Albert Kading | M | - |
Loyola Marymount University
| - |
Rhonda Bethea | F | - |
Loyola Marymount University
| - |
Kristi Frey | F | - |
Loyola Marymount University
| - |
Steven Dzida | M | - |
Loyola Marymount University
| - |
Gregory O'Meara | M | - |
Loyola Marymount University
| - |
Janice Clifford | F | - |
Loyola Marymount University
| - |
Terrence Buckley | M | - |
Loyola Marymount University
| - |
Stanley Chambers | M | - |
Loyola Marymount University
| - |
Anthony Delfino | M | - |
Loyola Marymount University
| - |
Fred Craves | M | 78 |
Loyola Marymount University
| - |
Michael Gagleard | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
Robert G. Horn | M | - |
Loyola Marymount University
| - |
Markos Tambakeras | M | 73 |
Loyola Marymount University
| - |
Maureen A. Kindel | F | 86 |
Loyola Marymount University
| - |
Kirk Calhoun | M | 80 |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | - |
Ajay Bansal | M | 62 | 5 years | |
Robert Sellers | M | - |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | - |
Walter J. Lack | M | 76 |
Loyola Marymount University
| - |
Lodwrick Monroe Cook | M | 95 |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | - |
R. Chad Dreier | M | 76 |
Loyola Marymount University
| - |
Ernst-Ludwig Winnacker | M | 83 |
Loyola Marymount University
| - |
Blake Bath | M | 61 |
Loyola Marymount University
| - |
Naveed Iqbal Siddiqi | M | - |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | - |
Thierry Laugel | M | 57 |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | - |
Thomas Paschall | M | - |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | - |
Norma Provencio | F | 67 |
Loyola Marymount University
| - |
James Dennison | M | - | 4 years | |
Thomas E. Larkin | M | - |
Loyola Marymount University
| - |
Cédric Moreau | M | 37 |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | - |
Russell Donda | M | - |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | - |
Gerald Alcantar | M | - |
Loyola Marymount University
| - |
Fernando J. Guerra | M | - |
Loyola Marymount University
| - |
Angela James-Hunt | M | - |
Loyola Marymount University
| - |
Christopher M. DeGiorgio | M | - |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | 12 years |
Ian A. Cook | M | 64 |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | 15 years |
Patrick Spine | M | 61 | 6 years | |
Felice Verduyn-van Weegen | F | - |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | 5 years |
Frank Valentino | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Douglas Ingram | M | 61 | 19 years | |
Julia C. Owens | M | 51 | 9 years | |
Louis Lavigne | M | 75 | 16 years | |
Jeffrey Edwards | M | 63 | 22 years | |
Louis J. Arcudi | M | 63 | 3 years | |
Andrew Kirkpatrick | M | 61 | 12 years | |
Herb Boyer | M | 87 | 19 years | |
Vivid Sehgal | M | 56 | 8 years | |
Joshua H. Levine | M | 66 | 10 years | |
Ambrose Bailey | M | 60 | - | |
Caroline F. van Hove | F | 43 | 17 years | |
Robert Weiss | M | 77 | 12 years | |
Jack Goldstein | M | 77 | 10 years | |
Jenny Tanujaya | F | 59 |
Pepperdine University
| 6 years |
Jean-Pierre Murray | M | 56 |
Pepperdine University
| 4 years |
Elizabeth Dávila | F | 80 | 15 years | |
Shigeyuki Hamamatsu | M | 51 | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 89 | 89.00% |
Bermuda | 7 | 7.00% |
France | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Hindman
- Personal Network